To address these limitations, we propose a novel method, Graph Mixup for Positive Sample Augmentation (GMPSA), to effectively combine positive drug molecule graphs and extend the training distribution ...

GAITHERSBURG, Md., June 26, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...